Top Markets
Coin of the day
OptiNose, Inc. OptiNose, Inc.

OptiNose, Inc.

OPTN
Rangering i aksjer #9145
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on... OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.
Aksjekurs
$9.60
Sist synkronisert: 2025-05-21
Markedsverdi
$1.08B
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel OptiNose, Inc. (OPTN)

Kategori

EPS for OptiNose, Inc. (OPTN)
EPS per March 2025 TTM: $-2.67
Ifølge de siste økonomiske rapportene og aksjekursen til OptiNose, Inc. er selskapets nåværende EPS (TTM) $-2.67. Ved slutten av 2023 hadde selskapet en EPS på $-0.32, en nedgang sammenlignet med EPS-en i 2022 som var $-13.05.
EPS-historikk for OptiNose, Inc. fra 2015 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-2.67 25.94%
2024 $-2.12 562.50%
2023 $-0.32 -97.55%
2022 $-13.05 806.25%
2021 $-1.44 -29.41%
2020 $-2.04 -21.54%
2019 $-2.60 -2.99%
2018 $-2.68 83.56%
2017 $-1.46 -505.56%
2016 $0.36 -108.39%
2015 $-4.29 0.00%
EPS for lignende selskaper eller konkurrenter